|
|
|
|
|
|
|
M T Wed Th F |
|
10 June, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wouldn’t you like to leave your job with a few million bucks? How about $35 million? $100 million? Andrew Dunn’s series on industry pay continues with a look at the golden parachutes some top executives snag for overseeing a corporate sale. |
|
|
|
Karen Weintraub |
Deputy Editor, Endpoints News
|
|
|
|
 |
|
|
|
by Andrew Dunn
|
A dozen biotech executives took home nearly $1 billion worth of exit packages from selling their companies, an Endpoints News analysis found. The drug industry... | |
|
|
|
|
|
|
by Kyle LaHucik
|
Novartis is doubling down on its partnership with Orionis Biosciences in a deal worth $40 million upfront and up to $1.4 billion spread across milestones... | |
|
|
|
|
|
|
by Nicole DeFeudis
|
SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
Shattuck Labs initiates $75M public offering: The US biotech STTK is sellingover 10.5 million shares for $4 apiece, and issuing pre-funded warrants for certain... | |
|
|
|
|
|
